Tasuku HONJO receives Nobel award in medicine for discovery of immunocheckpoint therapy for cancer
The prize will be jointly awarded with James Patrick Allison of MD Anderson Cancer Center. The drugs based on their work belong to a class of antibodies called checkpoint inhibitors, of which ipilimumab (brand name Yervoy), nivolumab (Opdivo) and pembrolizumab (Keytruda) are already approved. Born in 1942, Honjo studied medicine at Kyoto University, and was a […]